Long Term Open Label Treatment with Inhaled Treprostinil for Pulmonary Arterial Hypertension

被引：0
|
作者：
Voswinckel, R. [1 ]
van Dijk, J. [2 ]
Edelmann, R. [1 ]
Gall, H. [1 ]
Channick, R. [2 ]
Olschewski, H. [3 ]
Ghofrani, H. A. [1 ]
Seeger, W. [1 ]
Rubin, L. J. [2 ]
机构：
[1] Univ Giessen, Lung Ctr, D-35390 Giessen, Hesse, Germany
[2] UCSD, La Jolla, CA USA
[3] Univ Hosp Graz, Graz, Austria
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3352
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arterial Hypertension (TRIUMPH) study open-label extension
    Benza, Raymond L.
    Seeger, Werner
    McLaughlin, Vallerie V.
    Channick, Richard N.
    Voswinckel, Robert
    Tapson, Victor F.
    Robbins, Ivan M.
    Olschewski, Horst
    Rubin, Lewis J.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (12): : 1327 - 1333
  • [2] Inhaled Treprostinil for the Treatment of Pulmonary Arterial Hypertension
    Poms, Abby
    Kingman, Martha
    [J]. CRITICAL CARE NURSE, 2011, 31 (06) : E1 - E11
  • [3] Inhaled treprostinil for the treatment of pulmonary arterial hypertension
    LeVarge, Barbara L.
    Channick, Richard N.
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2012, 6 (03) : 255 - 265
  • [4] Inhaled treprostinil for treatment of chronic pulmonary arterial hypertension
    Voswinckel, R
    Ghofrani, HA
    Grimminger, F
    Seeger, W
    Olschewski, H
    [J]. ANNALS OF INTERNAL MEDICINE, 2006, 144 (02) : 149 - 150
  • [5] Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension
    Ferrantino, Matthew
    White, R. James
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (16) : 2583 - 2593
  • [6] Inhaled treprostinil and pulmonary arterial hypertension
    Nadler, Samuel T.
    Edelman, Jeffrey D.
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 : 1115 - 1124
  • [7] Tapit Treatment Of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil: An Open Label, Pilot Study
    Anderson, J. W.
    Robinson, J.
    Abbott, C.
    Meadows, C.
    Patel, M.
    Bajwa, A.
    Bull, T. M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [8] Inhaled Treprostinil In Pediatric Pulmonary Arterial Hypertension
    Rosenzweig, E. B.
    Krishnan, U.
    Takatsuki, S.
    Kerstein, J.
    Calderbank, M.
    Ivy, D. D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [9] The impact of comorbidities on inhaled treprostinil treatment in patients with pulmonary arterial hypertension
    Argula, Rahul
    Shapiro, Shelley
    El-Kersh, Karim
    Shen, Eric
    Kim, Hyoshin
    Broderick, Meredith
    Mclaughlin, Vallerie
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] Effectiveness and Safety of Inhaled Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Children
    Krishnan, Usha
    Takatsuki, Shinichi
    Ivy, Dunbar D.
    Kerstein, Jason
    Calderbank, Michelle
    Coleman, Elizabeth
    Rosenzweig, Erika B.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (11): : 1704 - 1709
12345